...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Acta Neurochirurgica >Procedural complications of endovascular treatment in patients with aneurysmal subarachnoid haemorrhage treated at a single centre
【24h】

Procedural complications of endovascular treatment in patients with aneurysmal subarachnoid haemorrhage treated at a single centre

机译：单一中心处理的动脉瘤蛛网膜下腔患者血管内治疗的程序并发症

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Abstract Background We present a single-centre experience of procedural complications suffered by patients undergoing endovascular treatment for a ruptured saccular intracranial aneurysm at Tampere University Hospital, Finland, between 2000 and 2014. Method From 2000 to 2014, we treated 1,253 patients with aneurysmal subarachnoid haemorrhage, 491 of whom received endovascular treatment. Clinical data were collected retrospectively from the hospital’s aneurysm database. A procedural complication was defined as having occurred whenever there was a documented new event in the patient’s medical records or a note of a technical complication written by an interventionist after endovascular treatment. Procedural complications could be with or without clinical symptoms. Results Nearly 40% (491/1253) of the patients were treated with the endovascular method. Procedural complications occurred in 11.4% (56/491) of cases. The morbidity rate was 4.5% (22/491) and the mortality rate was 0.2% (1/491). Of the 56 complications, ischaemic complications occurred in 52% (29/56), haemorrhagic complications occurred in 27% (15/56) and technical complications occurred in 21% (12/56) of cases. In 61% (34/56) of the cases, the procedural complication did not cause any clinical symptoms. Conclusions The total risk for procedural complications leading to postoperative disability or death at our institute was 4.7%. The complication frequency is in accordance with previous reports. Endovascular treatment of ruptured intracranial aneurysms is a safe treatment method when patient selection is carefully performed.
机译：摘要背景我们在2000年至2014年间，在芬兰的坦佩雷大学医院接受血管内颅内动脉瘤发生血管内颅内动脉瘤的患者患有血管内颅内动脉瘤的单一中心经验。方法从2000年到2014年，我们治疗了1,253名患者的动脉瘤蛛网膜瘤出血，491人接受了血管内治疗。临床数据从医院的AneurySM数据库中回顾性收集。每当患者的病历中有一个记录的新事件或在血管内治疗后的干预者写入的技术并发症的说明时，定义了程序并发症。程序并发症可能有或没有临床症状。结果患者的近40％（491/1253）用血管内方法治疗。程序并发症发生在11.4％（56/491）的情况下发生。发病率为4.5％（22/491），死亡率为0.2％（1/491）。在56个并发症中，52％（29/56）发生的缺血性并发症，出血并发症发生在27％（15/56），21％（12/56）案件中发生技术并发症。在案件的61％（34/56）中，程序并发症没有引起任何临床症状。结论我们学院术后残疾或死亡导致程序并发症的总风险为4.7％。并发症频率符合先前的报告。颅内动脉瘤破裂的血管内治疗是仔细执行患者选择时的安全处理方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号